Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

3 treatments under study, led by Plateletrich Plasma Injection

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
Phase 2 (1)

Trial Status

Recruiting1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT07396246Phase 2RecruitingPrimary

Comparison Between Transarterial Musculoskeletal Embolization and Platelet-Rich Plasma Injection for the Treatment of Greater Trochanteric Pain Syndrome

NCT03338465Not ApplicableCompleted

Extracorporeal Shockwave Treatment for Greater Trochanteric Pain Syndrome

Showing all 2 trials

Research Network

Common Treatments

  • Plateletrich Plasma Injection1
  • Duolith Sd1 Storz Medical Switzerland With Fsw Applicator1
  • Transarterial Musculoskeletal Embolization1

Active Sponsors

  • Serviço de Imagiologia da ULS Alto Ave1
  • Serviço de Ortopedia da ULS Alto Ave1
  • Unidade Local de Saúde do Alto Ave, EPE1
  • University of Roma La Sapienza1

Top Investigators

Related Conditions

  • Bursitis Hip1
  • Pain Syndrome1
  • Gluteal Tendinitis1
  • Mobility Limitation1

Activity Timeline